chr6-31671867-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021221.3(LY6G5B):āc.191T>Cā(p.Val64Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000418 in 1,604,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021221.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LY6G5B | NM_021221.3 | c.191T>C | p.Val64Ala | missense_variant | 3/3 | ENST00000375864.5 | NP_067044.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LY6G5B | ENST00000375864.5 | c.191T>C | p.Val64Ala | missense_variant | 3/3 | 1 | NM_021221.3 | ENSP00000365024 | P1 | |
LY6G5B | ENST00000409525.1 | c.26T>C | p.Val9Ala | missense_variant | 2/2 | 1 | ENSP00000386365 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000655 AC: 16AN: 244118Hom.: 0 AF XY: 0.0000376 AC XY: 5AN XY: 132942
GnomAD4 exome AF: 0.0000392 AC: 57AN: 1452314Hom.: 0 Cov.: 31 AF XY: 0.0000402 AC XY: 29AN XY: 720704
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.191T>C (p.V64A) alteration is located in exon 3 (coding exon 3) of the LY6G5B gene. This alteration results from a T to C substitution at nucleotide position 191, causing the valine (V) at amino acid position 64 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at